Exhibit 23.1

 

Draft Consent of Independent Registered Public Accounting Firm

We consent to the use in the Registration Statements to Form S-8 of Semnur Pharmaceuticals, Inc., of our report dated April 21, 2025, relating to the financial statements of Semnur Inc. (Legacy Semnur), as of December 31, 2024 (which report expresses an unqualified opinion and includes explanatory paragraphs relating to a going concern uncertainty, and the use of a carve-out basis of accounting discussed in Notes 1 and 2). We also consent to the reference to us under the heading “Experts” in such Registration Statement.

Pipara & Co LLP

/s/ Pipara & Co LLP

Delhi, India

December 03, 2025

 

New York Office:		Corporate Office:		Dubai Office:		Mumbai Office:		Delhi Office:		Hyderabad Office:
1270, Ave of Americas, Rockefeller Center, FL7, New York – 10020, USA +1 (646) 387 - 2034		“Pipara Corporate House” Near Bandhan Bank Ltd., Netaji Marg, Law Garden, Ahmedabad - 380006		1011, B-Block, Mazaya Centre, Sheikh Zayed Rd - Al Wasl - Dubai - UAE		#3, 13th floor, Tradelink, ‘ E’ Wing, A - Block, Kamala Mills, Senapati Bapat Marg, Lower Parel, Mumbai - 400013		Green Park Desq Work, Gate No. 1, 49/1 Yusuf Sarai, Nr. Green Park Metro Station, Delhi - 110016		509, Sandhya Techno - 1, Opp. KIMS Hospital, Raidurgam, Hyderabad Telangana, India, 500036
naman@pipara.com		T: + 91 79 40 370370		info@pipara.com		E: pipara@pipara.com		chintan.jain@pipara.com		sharyansh.ranka@pipara.com